SCHEMBL5586663

SCHEMBL5586663

CCCCOc1c(O)c(O)c(CC)c(OCCCC)c1OCCCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.39
NR5A1 Q13285 1/20 0.39
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
ESR1 P03372 6/20 0.35
TLR4 O00206 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP19A1 P11511 1/20 0.33
CYP2C9 P11712 1/20 0.33
GSTA1 P08263 1/20 0.33
GSTP1 P09211 1/20 0.33
GPR84 Q9NQS5 2/20 0.33
LMNA P02545 1/20 0.33
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
NR1H2 P55055 1/20 0.33
RNASEL Q05823 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5590537 0.92 LTA4H (0.39) LTA4HNR5A1THRATHRBESR1
SCHEMBL5587824 0.88 LTA4H (0.33) LTA4HTLR4GSTA1GSTP1
SCHEMBL5589063 0.87 LTA4H (0.38) LTA4HNR5A1THRATHRBESR1
SCHEMBL5588202 0.87 ALOX5 (0.41) LTA4HNR5A1THRATHRBESR1
SCHEMBL5589576 0.85 ALOX5 (0.46) LTA4HNR5A1ESR1CYP19A1LMNA
SCHEMBL5586608 0.85 LTA4H (0.39) LTA4HNR5A1THRATHRBESR1
SCHEMBL5587905 0.84 ALOX5 (0.49) LTA4HNR5A1ESR1GPR84LMNA
SCHEMBL5590393 0.84 ALOX5 (0.49) LTA4HNR5A1ESR1GPR84LMNA
SCHEMBL5588898 0.84 ALOX5 (0.49) LTA4HNR5A1ESR1GPR84LMNA
SCHEMBL5589090 0.84 ALOX5 (0.49) LTA4HNR5A1ESR1GPR84LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 LTA4H 147/4885NR5A1 2413/4885THRA 3787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.